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Abstract
Background: Randomised controlled trials (RCTs) are generally regarded as the “gold standard” for providing
quantifiable evidence around the effectiveness and cost-effectiveness of new healthcare technologies. In order to
perform the economic evaluations associated with RCTs, there is a need for accessible and good quality resource-
use data; for the purpose of discussion here, data that best reflect the care received.
Traditionally, researchers have developed questionnaires for resource-use data collection. However, the evolution of
routinely collected electronic data within care services provides new opportunities for collecting data without
burdening patients or caregivers (e.g. clinicians). This paper describes the potential strengths and limitations of each
data collection method and then discusses aspects for consideration before choosing which method to use.
Main text: We describe electronic data sources (large observational datasets, commissioning data, and raw data
extraction) that may be suitable data sources for informing clinical trials and the current status of self-reported
instruments for measuring resource-use. We assess the methodological risks and benefits, and compare the two
methodologies. We focus on healthcare resource-use; however, many of the considerations have relevance to
clinical questions.
Patient self-report forms a pragmatic and cheap method that is largely under the control of the researcher.
However, there are known issues with the validity of the data collected, loss to follow-up may be high, and
questionnaires suffer from missing data. Routinely collected electronic data may be more accurate and more
practical if large numbers of patients are involved. However, datasets often incur a cost and researchers are bound
by the time for data approval and extraction by the data holders.
Conclusions: Owing to the issues associated with electronic datasets, self-reported methods may currently be the
preferred option. However, electronic hospital data are relatively more accessible, informative, standardised, and
reliable. Therefore in trials where secondary care constitutes a major driver of patient care, detailed electronic data
may be considered superior to self-reported methods; with the caveat of requiring data sharing agreements with
third party providers and potentially time-consuming extraction periods. Self-reported methods will still be required
when a ‘societal’ perspective (e.g. quantifying informal care) is desirable for the intended analysis.
Keywords: Trial-based evaluation, Data collection methodology, Self-report, Routinely collected data, Large
observational datasets, Big data
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Background
Randomised controlled trials (RCTs) are generally
regarded as the “gold standard” form of clinical trial for
the purpose of providing quantifiable evidence around
the effectiveness and cost-effectiveness of new healthcare
technologies [1]. The importance of economic evalua-
tions alongside clinical trials to assess cost-effectiveness
has grown in recent decades, partly due to the need to
show ‘value for money’ when investing in new care tech-
nologies and specific evidence requirements by reim-
bursement governing agencies such as the National
Institute for Health and Care Excellence (NICE) in the
United Kingdom (UK) [2], as an example. Within-trial
economic evaluations rely largely on the acquisition of
data describing the resource-use of trial participants (e.g.
number of inpatient stays, outpatient visits, GP visits) to
which unit costs are applied to provide cost data to in-
form the evaluation [3]. CH Ridyard and DA Hughes [4]
conducted a systematic review of studies funded by the
UK Health Technology Assessment (HTA) program to
identify the different methods used for the collection of
resource-use data within clinical trials; the majority of
studies identified (61 of 85) used at least two methods,
typically involving patient- or carer-completed forms
and medical records (e.g. patient notes, large database),
the latter of which is referred to as ‘routinely collected
care data’ within this manuscript.
The aim of this paper is to compare the two afore-
mentioned methods for collecting resource-use infor-
mation for trial-based economic evaluations: (1)
self-reported methods, whereby ‘self-report’ is by the
patient about their own resource-use; (2) methods for
using routinely collected resource-use data from elec-
tronic sources such as electronic versions of medical
notes on administrative systems and large healthcare
databases, which can contain information about indi-
viduals and cohorts of patients. We focus mainly on the
acquisition of healthcare resource-use data (e.g. use of
inpatient hospital care and seeing a nurse in a GP prac-
tice or home setting) rather than clinical outcome data
(e.g. hospital anxiety and depression scale scores) as the
focus here is specifically on data normally used for the
purpose of economic evaluation; however, many of the
considerations described also have relevance to other
forms of clinical and health-related data which may be
routinely collected and/or patient-reported. We also
mainly focus on person-level data rather than aggre-
gated data, because these are most desirable for
trial-based evaluations. It should be noted that there
are also objectively measured outcomes and
investigator-reported data, which although may be rou-
tinely collected and used for clinical trials, are outside
of the scope of this paper as these methods are rarely
used to collect resource-use data.
The databases described within this manuscript are
those which we, the authors, perceive to be the most
popular used for the purpose of economic analyses; there-
fore, the databases described should not be considered a
comprehensive list of all routinely collected data sources.
We describe the potential strengths and limitations of
each data collection method using specific databases as
examples, and then discuss aspects for consideration be-
fore choosing which method to use when collecting
resource-use data for trial-based evaluations. A compiled
list of select websites is provided in Additional file 1: S1 to
give the reader more information about the databases,
software systems, and national Information Technology
(IT) programmes mentioned in this paper.
A note on information governance, data protection, and
de-identified data
There are important data protection aspects to consider
when using person-level data which are outside the scope
of this paper; however a brief overview is provided in this
section. It is important to note that, by law, National Health
Service (NHS) Digital (the NHS’s internal IT provider), pre-
viously known as the Health and Social Care Information
Centre (HSCIC), is the only organisation outside of direct
care providers in the UK that can handle personal identifi-
able data (PID); however, licensed/approved organisations
can also handle PID and trials are required to have explicit
consent for PID. This paper focuses on person-level data
for consenting people, so it is worth noting that
self-reported and electronic data are governed by stringent
information governance (IG) and data protection policies
and regulations such as the General Data Protection
Regulation (GDPR), which often requires de-identification
(anonymisation, pseudo-anonymisation, and removal of
person-identifiable data as required) of person-level data
before it can be used for research purposes. Identification
of people in electronic datasets normally requires explicit
consent from patients included in studies for their NHS
number to be used. Unique identifiers such as NHS
number along with explicit consent are integral
steps for using electronic data in most cases for tri-
als (note, this might not be the case for observa-
tional studies using anonymised routine data);
although, under GDPR, the legal basis for accessing
such data is normally for research purposes, with
consent alone no longer being the legal basis for
accessing such data. These considerations are too
complex to describe in detail here; however, these
aspects will be discussed as something to consider
when using either data collection method. Re-
searchers should make enquiries about the neces-
sary IG policies and data sharing agreements (DSA)
as required.
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Main text
Overview: Use of self-reported and routinely collected care
data
Traditionally, trial-based economic evaluations were
largely reliant on self-reported methods for collecting
resource-use information about the care resources people
consumed. However, since the National Programme for
IT, which ran from 2002 until 2013, prompted UK health
and social care services to record person-level care-related
data using Electronic Health Record (EHR) systems, there
has been a keen interest in how to utilise these routinely
collected data. These systems are usually designed by in-
dependent contractors, specifically for the administrative
needs of the service while conforming to national specifi-
cations (e.g. general practitioner systems of choice [GP
SoC] specifications [5]), and could provide a rich source of
data (both resource use and clinical outcomes) for analysis
in clinical trials rather than requesting similar data from
the patient directly (e.g. how often the patient saw their
GP or number of days spent as an inpatient). NHS Digital
and other providers currently offer a variety of electronic
databases for research and commissioning purposes.
However, consenting trial participants may not have their
data stored in these databases, data from any large data-
base usually has both monetary and logistical costs, and
the database may not contain appropriate Personal Identi-
fiable Data (PID e.g. NHS numbers) to link data with par-
ticipants. Owing to the complexities and cost of accessing
data from routine sources, self-reported questionnaires
are still commonly used to collect data for the purposes of
research studies. Different types of resources may be col-
lected using these two different methodologies; for ex-
ample, hospital stays might be collected using routine data
while informal carer arrangements, such as how much
time a son cares for his elderly mother, would typically be
collected by questionnaire because these data are probably
not routinely collected. Some studies have used
patient-report [4, 6, 7] and some have used a combination
of patient-report data and collecting data from databases
to provide complementary (i.e. each data collection
method provides different information for the trial) or
even substitutive (i.e. each data method provides similar
information for cross-checking or validity assessment of
the data obtained) information [8–10]. Even when admin-
istrative datasets are available, there are conflicting reports
of the validity of routinely collected data compared with
patient-reported data even when the data collected is per-
ceived to be based on the same type of resource-use [11].
Therefore, neither data collection method can currently
be considered the ‘gold standard’ for the purpose of
informing trial-based analyses; rather, it is up the re-
searcher to decide on which method to use dependent on
the circumstance (e.g. trial design, setting, aims and objec-
tives) and the data of interest for the trial.
Self-reported methods
Many trials employ data-collection methods based on
patient recall [4], in part because a questionnaire is rela-
tively cheap. Use of questionnaires allows the researcher
to control data collection to a large degree, as it does
not rely on third parties granting access; the value of this
element of control should not be underestimated in trial
situations with significant time pressures. Researchers
can also tailor questionnaires to request specific infor-
mation needed for analysis. This is particularly import-
ant when an economic analysis from the societal
perspective is planned, as data on patients’ productivity,
travel methods, and informal care or childcare require-
ments, for example, can only come from the patient.
However, relying on patient recall has some significant
disadvantages. Patients tend not to be able to recall their re-
source use accurately [12] and this gets worse as the time
period over which they must remember increases (e.g.
retrospectively remembering the care they have received
over 3 or 6month periods); if the inaccuracy is systematic-
ally different between trial arms, it can constitute a recall
bias, leading to biased estimates. Data entry clerks can
introduce mistakes when capturing data electronically from
paper-based questionnaires, either by simple typographical
error or by reinterpreting non-standard responses in an ar-
bitrary fashion. Completing questionnaires is time consum-
ing for patients; researchers (and ethics committees) prefer
to minimise the research burden placed on patients and pri-
mary investigators are often keen to minimise the amount
of space taken up by resource-use questions. Although
adjusting for baseline differences in resource-use is recom-
mended as part of statistical analyses associated with trials
[13], collecting data by patient recall at baseline involves an
additional burden on patients, and is typically not under-
taken. As a result of many of these issues, resource-use
questionnaires tend to suffer from missing data [14].
In terms of the practical development and administra-
tion of questionnaires, there is a significant amount of
research time wastage. These instruments are rarely vali-
dated [4], and even more rarely re-validated when used
with alterations or in a different context. Reporting also
tends to be poor [7]. As a partial solution to some of
these problems, the Database of Instruments for
Resource-Use Measurement (DIRUM) was created as a
repository for instruments based on patient recall
(www.dirum.org). It is a useful source for researchers
wanting to find an instrument that may be reusable in
their own work and the database is recommended for
use by the International Society for Pharmacoeconomics
and Outcomes Research (ISPOR) taskforce on good re-
search practices [15].
Standardisation of patient-reported outcome measure-
ment in economic evaluation has been accepted as a
principle for some time, with NICE recommending the
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use of the EuroQol five-dimension (EQ-5D) instrument
[16, 17] as a measure of preference-weighted health sta-
tus [2] to enable cross-comparison of outcomes across
trials. Standardised instruments for patient-reported cost
measurement have also been developed, with the Client
Service Receipt Inventory (CSRI) the most commonly
used and validated example [18]. However, the CSRI was
originally developed to be administered as an interview,
which is a costly means of gathering data and impracti-
cal in many trials. It has also been adapted many times,
with over 200 versions believed to have been used [19],
and was created specifically for use with patients with
mental health conditions. It is therefore neither fully
standardised nor universally applicable. The Annotated
Patient Cost Questionnaire (APCQ) [20] was a more re-
cent attempt to standardise cost measurement, and has
invoked much interest since being deposited on DIRUM.
However, it requires some effort to use effectively and,
although it appears to perform well in validation studies
[21], has not yet been widely adopted. Other standar-
dised resource-use questionnaires have been developed,
including one in Dutch [22], one for cancer trials [23],
and one for patients with dementia [24], but a standar-
dised (and well validated) instrument that is relevant to
all trials and could be used ‘off the shelf ’ by researchers
in the UK is lacking. While this ideal may not be fully
achievable, a recent Delphi survey based on the opinions
of health economists with experience of UK-based trials
found that it was possible to identify a list of 10 essential
items that should be included in such a standardised in-
strument [25], with additional modules identified as im-
portant in some cases.
Electronic data sources of routinely collected data
Within this section we explore the use of routinely col-
lected data; from raw data extracted straight from the
service up to the level of linked datasets across multiple
services, and the evolution of more efficient trial designs
utilising these data.
Raw data extraction
Raw data extraction can include anything from direct
system data extraction and anonymization to recording
data from computer screens into data extraction forms.
Of 63 studies that used patient-reported methods, 43
supplemented these data with routine sources such as
GP records, hospital notes, and hospital databases [4]. A
previous study by M Franklin, V Berdunov, et al. [26] ex-
tracted raw data from a range of services, including hos-
pitals’ Patient Administration Systems (PAS), primary
care practice EHR software systems (including Syst-
mOne [27], EMIS [28], and Vision [29]), as well as from
the electronic systems of intermediate care, mental
health trust, ambulance, and social care services; these
methods were then used to obtain data for two subse-
quent RCTs [30, 31]. It is worth noting that when
obtaining primary care data and other external service
data (e.g. community care), SystmOne proved particu-
larly useful within these studies because remote access
was possible due to the central database and interoper-
ability of this system – information pertaining to pa-
tients’ care from any SystmOne system can be held
centrally and then accessed providing a smart card with
appropriate permissions from the practice has been
gained (and the person and service have consented to
certain data access) [26, 32, 33]. However, the permis-
sions and time required to obtain data from all these dis-
aggregated services and their electronic systems makes
obtaining such data labour intensive and so not viable
for many studies.
Primary care data have been particularly disaggregated
among a number of software systems (e.g. EMIS, Syst-
mOne, Vision) [34] and clinical coding systems (e.g.
Clinical Terms Version [CTV3] and Read Version 2)
which has caused issues for researchers. MIQUEST was
an example of a stand-alone query language within GP
practices that could be used to extract certain data pa-
rameters; however, the output from such a query lan-
guage limited its use for economic analysis despite its
benefits for patient identification based on characterising
patients using Read codes (such as if patients with a par-
ticular condition need to be identified for a study, for ex-
ample) [35–38]. A current move to the Systematized
Nomenclature of Medicine - Clinical Terms (SNOMED
CT) as a single clinical terminology within primary care
[39] and across other care settings [40] could deal with
some cross-system data extraction issues, but this will
need to be examined in future research; it should also be
noted that due to the implementation of SNOMED CT,
NHS Digital announced that they would not be under-
taking any future development work on MIQUEST (as it
was not compatible with SNOMED CT) and advised
that organisations plan to transition away from
MIQUEST by April 2018 [41, 42]. Attempts to enable
better formats for extracted information from primary
care software systems, such as the Apollo software sys-
tem [10, 43, 44], could enable trial-based analysis and
should be assessed in future research.
Raw data collection often requires aid from data pro-
cessors or those with knowledge of health informatics at
the service, or researchers with appropriate knowledge,
training and permission to access and process the data.
This imposes a practical restriction on researchers using
the systems as they must liaise with third parties.
NHS digital and commissioning datasets
NHS Digital provides a variety of electronic datasets (see
Table 1 for examples), offering access through their Data
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Access and Request Service (DARS) dependent on a
five-stage process (application, approval, access, audit, and
deletion). NHS Digital have appropriate permissions to han-
dle PID and therefore accessing data for consenting patients
is in theory feasible assuming information governance (IG)
and data-sharing agreements can be arranged; this may not
be possible with other datasets (see section titled "Other
large observational datasets: Primary care").
NHS Digital’s Hospital Episode Statistics (HES) dataset
has become popular for the purpose of analysis within
England. HES provides a large amount of aggregated or
person-level hospital care data and unified codes, such
as: International Classification of Diseases version 10
(ICD-10); Office of Population and Surveys Censuses
(OPCS) Classification of Interventions and Procedures
version 4 (OPCS-4) codes; and Healthcare Resource
Group (HRG) codes which can be linked with reference
cost data [45, 46]. However, note that HES only has
HRG codes until 2012; researchers will need to use HRG
software toolkits to derive HRGs for the latest HRG ver-
sion 4+ (HRG-4+) [47, 48] and earlier versions (e.g.
HRG-4 and HRG v3.5) [48] from codes within HES.
In addition to HES, NHS Digital provides a variety of
electronic datasets including:
 Secondary Uses Service (SUS) [49] (note, HES
comes from SUS);
 General Practice Extraction Service (GPES) [50]
(note, part of the GP collections service [51]
alongside the Calculating Quality Reporting Service
[CQRS] to record practice participation and to
process and display information);
 Diagnostic Imaging Dataset (DIDS) [52];
 Improving Access to Psychological Services (IAPT) [53];
 Mental Health Minimum Data Set (MHMDS) [54].
Not all the data provided in these datasets are useful for
the purpose of clinical or economic evaluations, but they
are useful examples for indicating the amount of elec-
tronic data available. Descriptions of these databases and
links to their data dictionaries are provided in Table 1. It
is also worth noting that various mental health datasets
have or may be amalgamated into the Mental Health Ser-
vices Data Set (MHSDS) [55] (see also Table 1).
NHS Digital also provides datasets for commissioners,
such as the current Clinical Commissioning Groups
(CCGs: clinician-led bodies responsible for commissioning
healthcare services within a local area). The data flows via
the Data Services for Commissioners Regional Offices
(DSCROs), who provide data to a CCG for their geograph-
ical area of interest and responsibility only. The CCG may
also have ‘local data’ flows such as from acute, primary,
mental health, and social care services to supplement
NHS Digital data. Partnerships between commissioners
and researchers can benefit both parties and patients
through the research objectives and outcomes that could
be achieved by sharing data. However, these datasets are
governed by legislation and, often, NHS Digital policies;
the CCG are bound by the terms of their data sharing
agreement with NHS Digital.
Other large observational datasets: Primary care
For primary care data, a variety of datasets exist (which
obtain their data from specific GP software systems) in-
cluding: Clinical Practice Research Datalink (CPRD;
traditionally obtains its data from the Vision system, al-
though has reportedly started obtaining data from prac-
tices with the EMIS system and is piloting to obtain data
from SystmOne) [56, 57]; The Health Improvement Net-
work (THIN; Vision) [58]; ResearchOne (SystmOne)
[59]; and QResearch (EMIS) [60].
However, these primary care databases do not allow
access to PID (e.g. NHS number) and therefore are
not suitable for existing trial-based evaluations with
consenting patients. Note that although PID cannot
be accessed through these databases, the database
providers may be able to extract data from primary
care systems for consenting patients (for example,
ResearchOne explicitly offer such a service on their
website); there is also still potential to develop more
efficient study designs using databases such as these
(e.g. CPRD) while maintaining the anonymised nature
of the data (e.g. no PID; see section titled "Efficient
study designs using large observational datasets"). It is
worth noting that L McDonnell, B Delaney and F Sul-
livan [61] have compiled a more comprehensive list
of UK primary care datasets that may be of interest.
Linked datasets
An issue with electronic datasets is that they may only
adequately record data for patients who use that particu-
lar service. Previous studies have already described the
need for linked data when assessing the burden of injury
[62] and for myocardial infarction [63]. This aspect has
also been raised as a potential issue when interpreting
information about external care services (e.g. hospital
and community services) recorded within primary care
[64, 65]. There have been attempts at linking datasets,
for example: (i) Hospital Episode Statistics (HES) has
data linkages with the Office for National Statistics
(ONS) mortality data (including causes of death),
PROMs (patient reported outcome measures), diagnostic
imaging, and MHMDS datasets; (ii) a subset (approxi-
mately 75%) of consenting CPRD English practice
data can be linked with HES, ONS (mortality data),
area-based deprivation data, and Cancer Registry UK
data [64].
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Table 1 An overview and summary of some potential electronic databases for resource-use information; please note that the list is
not exhaustive
Name of database/ service software Service category Comments about the data Data dictionary
(Yes/No)
Primary care databases
Clinical Practice Research Datalink (CPRD) Primary care Collects data from Vision (historically), EMIS (more
recently), and potentially SystmOne (being piloted at
time of writing) GP practice software systems.
Reportedly covers over 11.3 million patients (4.4
million active patients) from 674 practices in the UK
b
– this was the figure reported for just Vision
practices.
Yes (Read code based)
The Health Improvement Network (THIN)
database
Primary care Collects data from Vision GP practice software
systems. Reportedly covers 11.1 million patients (3.7
million active patients) from 562 general practices in
the UK b
Yes (Read code based)
ResearchOne Primary care (and other
contributing
organisations – see
‘comments’)
Collects data from SystmOne GP practice software
systems. Also reportedly collects data from other
services using SystmOne. As of 2013, ResearchOne
reportedly includes 5 million health records from 400
contributing organisations across 10 organisation
types (ranging from hospitals to end-of-life
organisations)b
Yes (Read code based)
QResearch Primary care Collects data from EMIS GP practice software
systems. Based on current publications associated
with this dataset, unsure what resource-use data is
available as not used for economic studies. As of
2015, the database reportedly obtains data from a
sample of approximately 1000 practices covering a
population of 18 million peopleb
Yes (Read code based)
NHS Digital databases
Secondary Uses Service (SUS) Healthcare data Designed to provide anonymous patient-based data
for purposes other than direct clinical care, such as
healthcare planning, commissioning, public health,
clinical audit and governance, benchmarking, per-
formance improvement, medical research and na-
tional policy development. SUS will only provide
data for the region of interest to the commissioners
if obtained through NHS commissioners. SUS is up-
dated once a month.
Yes (note, includes a
variety of
commissioning data)d
Hospital Episode Statistics (HES) Secondary care Hospital care data (inpatient, outpatient, A&E, and
critical care). Once a month and at pre-arranged
dates during the year, SUS takes an extract from their
database and sends it to HES – it is this data which
populates the HES database.
Yes (online)e
General Practice Extraction Service (GPES) Primary care GPES is part of the GP collection service alongside
the Calculating Quality Reporting Service (CQRS)
used to record practice participation and to process
and display information. GPES collects primary care
information from GP IT systems and then presents it
at a National level. Used to inform GP payments.
Collects both anonymised and person-identifiable
data (PID; when permitted). Main focus is clinical
data (i.e. Quality Outcomes Framework [QOF] data),
not resource-use data.
General overview of
data that can be viewed
in GPES is listed onlinef
Diagnostic Imaging Dataset (DIDS) Diagnostic NHS-funded diagnostic imaging tests Yes (online)g
Improving Access to Psychological
Therapies (IAPT)
Mental health Adults in receipt of NHS-funded IAPT services (see
data dictionary).
Yes (online)h
Mental Health Services Data Set (MHSDSb Mental health Record-level data on care of children, young people
and adults who are in contact with mental health,
learning disability or autism spectrum disorder
Yes (online)i
Franklin and Thorn BMC Medical Research Methodology            (2019) 19:8 Page 6 of 13
Table 1 An overview and summary of some potential electronic databases for resource-use information; please note that the list is
not exhaustive (Continued)
Name of database/ service software Service category Comments about the data Data dictionary
(Yes/No)
services.
Raw data extraction based on study by M Franklin, V Berdunov, et al (2014)a
Patient Administration System (PAS) Hospital Hospitals collect data into PAS (in Sheffield this is the
Lorenzo system, which is a well-established system
in England). This dataset includes basic hospital activ-
ity (i.e. inpatient, outpatient, and A&E); other detailed
clinical information may be held on other hospital
systems.
See HES data dictionary
for a general overview
SystmOne, EMIS, Vision Primary care SystmOne, EMIS and Vision currently dominant
primary care software systems in England. Each
collects and records data slightly differently, but
underlying data are coded based on Read Codes
(most if not all should be using SNOMED CT by April
2018). Note, the methods used by Franklin et al
(2014) did not rely on the use of Read Codes, rather
front-end report outputs which were processed
using visual basic for application (VBA) scripts.
See ‘Read Codes and
SNOMED CT’
Intermediate care, mental health trust,
ambulance services, and social care
systems
Various services The study by M Franklin, V Berdunov et al (2014)
collected raw electronic data from all these systems.
It is possible to collect these data after discussion
with the service and consent agreements from the
patients of interest.
No – data based on
discussion with services
Technology for future consideration
Read Codes and SNOMED CT Primary care Read codes can be obtained from the Technology
Reference data Update Distribution (TRUD) website.
SNOMED CT is a more unified coding base than
current Read codes. Software systems have been
developed to export information from primary care
systems in a more usable manner, such as the Apollo
software system.
Yes – a Read Browser
and Read codes are
required j
GP Connect and Data Commissioning
Flows
Primary care (initially) GP Connect and Data Commissioning Flows works
are in their early stages; it is difficult to gauge the
possible benefits these plans will bring from a
researcher perspective.
N/A
Bespoke linked dataset examples
NorthWest EHealth linked database Linked datasets Information on medications, symptoms and use of
healthcare facilities.
Contact provider
CALIBER dataset Linked datasets Linked data for primary care (CPRD), coded hospital
records (HES), social deprivation information and
cause-specific mortality data (ONS).
Contact provider
Footnote. Website references for all of the aforementioned databases and software systems are provided in Box 2. Links to online data dictionaries, if available,
are listed at the end of this footnote
aThese figures were reported on the databases own website and were still present on the website as of 10th April 2017
bResource-use data could be a part of any database in theory because some of these aspects are coded in the services; however, they are only useful if the data
are then included in the larger databases at the person-level (rather than national level, such as for GPES)
cNote, based on comments from the NHS Digital Standardisation Committee for Care Information (SCCI) in 2015(https://nhs-digital.citizenspace.com/scci/mhsds/),
MHSDS is a change to the Mental Health and Learning Disabilities Data Set (MHLDDS) that supersedes and replaces this standard, as well as the following: Child and
Adolescent Mental Health Services (CAMHS) data set; Mental Health Care Cluster; Mental Health Clustering Tool; Learning Disabilities Census (LDC), included in Assuring
Transformation standard. MHSDS will also incorporate the requirements of Children and Young People’s Improving Access to Psychological Therapies (CYP IAPT)
dSUS data dictionary (includes a variety of Commissioning Data Sets
[CDS]): http://www.datadictionary.nhs.uk/data_dictionary/nhs_business_definitions/s/secondary_uses_service_wu.asp?shownav=1
e HES data dictionary: https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics/hospital-episode-statistics-data-dictionary
f CQRS services and data that can be viewed in GPES: https://digital.nhs.uk/services/general-practice-extraction-service#types-of-data
g DIDS data dictionary: http://www.datadictionary.nhs.uk/data_dictionary/messages/clinical_data_sets/data_sets/diagnostic_imaging_data_set_fr.asp?shownav=1
h IAPT data
dictionary: http://www.datadictionary.nhs.uk/data_dictionary/messages/clinical_data_sets/data_sets/
improving_access_to_psychological_therapies_data_set_fr.asp?shownav=1
i MHSDS data
dictionary: http://www.datadictionary.nhs.uk/data_dictionary/messages/clinical_data_sets/data_sets/mental_health_services_data_set_fr.asp?shownav=1
j Read codes (https://isd.digital.nhs.uk/trud3/user/guest/group/2/pack/9) and SNOMED CT UK edition (https://isd.digital.nhs.uk/trud3/user/guest/group/2/pack/26)
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Other examples of linked datasets described in Table 1
include the (i) NorthWest EHealth linked database and (ii)
Clinical research using LInked Bespoke studies and Elec-
tronic health Records (CALIBER) dataset. For the latter,
the practical issues with using linked data have been de-
scribed by M Asaria, K Grasic and S Walker [66]. Linking
datasets is important to obtain the best possible data for
the services of interest and is an aspect for consideration
if the proposed analysis requires a more holistic approach
rather than focussing on a single service.
Efficient study designs using large observational datasets
There is currently a move to enable RCTs to be car-
ried out in large databases of routinely collected data
while retaining the anonymised nature of the data –
these have been described as ‘efficient’ [65] and ‘prag-
matic’ [67] study designs. Using data from existing
patient groups within these large observational data-
sets has been suggested as a way to enable patients
to be entered into RCTs more quickly than traditional
study designs [67]; however, without patient consent,
these data must be kept anonymised for research pur-
poses. CPRD have designed methods for interven-
tional research to take place within the confines of
their anonymised dataset by enabling practices to re-
cruit patients and then randomise them to a treat-
ment before data are then entered into the EHR
records and anonymised as normal [68]; an example
of a cluster RCT and economic evaluation within
CPRD is the PLEASANT trial [65, 69, 70]. Another
example of an efficient study design using similar
methods includes the Salford Lung Study [44] using
the NorthWest EHealth linked database. Although
these trial designs are not currently the norm, they
represent a methodology which may enable trials and
the accompanying analyses to utilise routinely col-
lected electronic data; however, such trials are con-
strained to rely only on the data routinely collected
within the associated large database, meaning it may
not be viable for all trials dependent on the relevant
trial outcomes and associated data requirements.
Discussion
In theory, EHRs should provide more detailed and ac-
curate resource-use data than self-report, as these da-
tabases are meant to represent the care patients have
actually received. There are also factors affecting the
accuracy of self-reported data including simple recall
errors, or a patient’s lack of knowledge about care
structures (potentially leading to appointments with
nurses being reported as doctors, for example). As
such there seems to be a push towards using elec-
tronic databases of routinely collected data rather
than self-reported methods, although relieving the
burden on patients receiving care is also a major
driver for using these databases. There is also a cost-
ing perspective argument that because electronic data
inform reimbursement, such as through payment by
results (PbR) [71], these are the data that should be
used as part of an economic evaluation. However, not
all electronic datasets are designed to be used as a
data source for clinical trials and there is “cautious”
support of the exchangeability of both self-reported
and administrative resource-use measurement
methods in the empirical literature [72–74]. In a
European Delphi study to produce consensus-based,
cross-European recommendations for the identifica-
tion, measurement and valuation of costs in health
economic evaluations, the recommendation was to
use patient-report for measuring resource use (and
lost productivity) over electronic sources, such as
large databases, as such databases don’t cover all ne-
cessary care services [75].
For hospital data, there has been an attempt at uni-
fied data processing and coding. Inpatient and out-
patient data from HES are reasonably valid for
research [76], although clinician engagement has been
questioned [77] and time delays for obtaining HES
data have been a concern for researchers working to
tight study time horizons. In GP records, negative
systematic bias has been demonstrated with patients
consistently reporting higher numbers of non-GP con-
tacts than GP records; this questions the reliability of
primary care systems for recording external care data
[73]. Such reliability concerns have been used as
rationalisations for needing linked datasets [62, 63,
65]. Current proposed innovations to enable better
interoperability (and potentially better linked data) in-
cludes GP Connect [78]. The long term vision of GP
Connect is to enable interoperability between systems,
with an initial idea to develop this link using the
Digital Interoperability Platform, an NHS Digital
Spine service [79]. NHS England are also planning
some National Commissioning Flows work to stream-
line the flow of healthcare data: one aspect of this
work is to improve national datasets and to drive im-
provements to standardised data definitions [80].
These innovations could improve data flows and
therefore improve access and connectivity between
different services and their datasets to improve pa-
tient care and assessments, perhaps eventually moving
to fully integrated care records. However, historically,
national attempts at linking electronic care systems
have not been able to achieve fully integrated care re-
cords, with key reasons being attributed to poor pro-
gress with intended deliverables associated with
unnecessary costs/spending in an evolving IT system
for the National Programme of IT [81–83], and a
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Table 2 Aspects to consider when choosing to obtain resource-use data using self-reported or electronic methods
Aspects to
consider
Self-reported Electronic database
Access to person-
level or record-
level data
Data reported by the patient themselves (or a proxy on their
behalf) are patient-level by definition.
Currently a major issue for electronic datasets. To those
without advanced knowledge of large datasets, it is unclear
whether person-level data can be obtained and the IG aspects
for obtaining these data are challenging for researchers. There
may also be a restricted data flow of person-level data de-
pending on the current stance of the data holders of what
constitutes appropriate data protection policies (e.g. NHS
Digital)
Service for which
data are required
Essential for services with no electronic records; for example,
travel, childcare, over-the-counter medications
All care services should operate an electronic administrative
system from which data could be obtained – will only collect
data based on care service provided or if linked to another
service (e.g. CPRD linked to HES; SystmOne central database).
Practicality and
cost
Pragmatic and cheap method which is well understood and
largely under the control of the researcher
Large datasets often incur a cost and the researcher is bound
by the time for data approval and extraction by the data
holders. Raw data extraction can be time consuming and
relatively costly compared with self-reported methods.
Number of
patients
Administratively burdensome for large numbers of patients If a large dataset exists and contains some person-level identi-
fier code (e.g. NHS number), then obtaining data for large pa-
tient numbers is possible. For raw data extraction, less
practical for large numbers of patients unless a systematic
method for data extraction is available (e.g. software system
for data extraction).
Validity of data Known issues with validity of self-reported data, particularly prob-
lematic if differential between arms. Can be tested in a pilot
phase.
Large databases have been known to validate their data;
however, the extent to which these data are validated is not
transparent, and validity for costing purposes may not have
been tested. Raw data are complicated to validate.
Time horizon for
analysis
Loss to follow-up may be higher with a lengthy time horizon.
Self-reported methods may work better for shorter time horizons
(i.e. one questionnaire per 3 month time period of interest).
Depends on time horizon of the database. Loss to follow-up
can occur in large datasets and raw data depending on the
database or service (e.g. GP practice may change system
restricting eligibility to provide data to particular primary care
datasets).
Patient group
being analysed
Care may be needed with particular patient groups who lack
capacity, for example
Different patient groups may use different services from
which data may need to be obtained. Type of patient (e.g.
cognitive ability) is not generally a concern.
Type of costing
exercise
(e.g. top-down or
micro-costing)
Can be tailored exactly to the type of costing exercise required
but depends on knowledge of patient to provide the detail of
care consumed. More time consuming collecting detailed
information for micro-costing exercises.
Raw and large datasets can offer aggregated or very detailed
information based on the level of data recording. Some data
offered may still not be reliable for micro-costing (e.g. time
with patient recorded in large databases such as CPRD).
Recall bias Problematic if differential recall errors exist systematically
between arms of a trial
Recall bias is not an issue, but potential bias relies on accurate
data recording at the service-level.
Missing data A known problem with self-report; can be minimised by follow-
ing good practice
Missing data is not a ‘known’ issue – if data are missing, then
not easy to assess (i.e. it would be assumed there was no
resource-use). Some evidence of data missing from HES, but
would be difficult to assess extent in a trial.
Regional or
national study
Data can be collected consistently across geographical areas More detailed datasets are available regionally than nationally.
National datasets depend on service uptake to provide
electronic data. Raw data may be difficult to obtain
electronically if there is no remote access to the software
system (e.g. remote access is possible with SystmOne).
International
studies (outside of
England)
Self-reported data is still necessary for many countries and
necessary in circumstances where electronic systems are not
available or cannot provide the data required.
More countries are using electronic data provided by care
services, commissioners, and insurance companies (to name a
few sources). This is important to note when comparing
analysis in England with other international studies.
Comparably, this may limit our (i.e. studies based in England)
ability to perform the best possible analysis which is desirable
as part of research studies.
All-cause or
disease specific
assessment
Patients may struggle to correctly identify whether an event is
related to their condition or not
A variety of codes (e.g. ICD-10 and OPCS-4 for in-hospital
codes) and free text to specify whether resource-use is associ-
ated with a condition. Primary care data has Read or SNOMED
CT codes for specific conditions and diseases, although these
codes are not always used appropriately. Free text is difficult
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perceived lack of data security/patient data protection
for the care.data programme [84]. As such, informa-
tion governance (IG) evolves and accessing electronic
person-level data for research becomes too compli-
cated and time-consuming. A previous study has cate-
gorised the challenges of accessing routinely collected
data from multiple providers in the UK for primary
studies into five themes [85]: data application process;
project timelines; dependencies and considerations re-
lated to consent; information governance; contractual.
Such challenges are difficult, time consuming, and
even costly to overcome; therefore, electronic data
methods may be pushed to the side in favour of using
and refining simpler, self-reported methods.
The literature on questionnaire development is ex-
tensive and improvements could be made by follow-
ing evidence-based guidelines [86]. However, a
number of questions surrounding best practice re-
main. For example, the optimum recall period has
not been established [87]; recalling salient events such
as hospital admissions over a year may be adequately
accurate for the general population (perhaps less so
for people with cognitive impairment or people re-
ceiving integrated care across multiple services),
whilst commonplace events such as GP appointments
may require a much shorter recall time period. The
scope of the questions can lead to problems for pa-
tients identifying relevant events; for example, if a pa-
tient is asked to report only resource-use relevant to
their diabetes, they may struggle to correctly identify
that a fall is relevant.
Social care data are not discussed in this paper be-
cause of the nature of the systems used. Healthcare
systems are more usable for obtaining data relative to
social care systems because of aspects such as the in-
clusion of unique identifiers (NHS number or other
pseudo codes), relatively more standardised coded
data, established national data dictionaries, and na-
tional software and system requirement (e.g. GP
SOC). A structured discussion around social care data
would be more complex because of the lack of struc-
ture of social care systems; however, social care is an
area which requires consideration in the future.
Based on this discussion, there are a number of key
elements a researcher may want to consider before
deciding on a data-collection method alongside an
RCT or any clinical trial which requires patient-level
data (see Table 2).
Conclusions
Until electronic databases become more integrated
across care services and more reliable in terms of
data processing and extraction alongside tight time
restrictions, self-reported methods will be used for
collecting resource-use information and electronic
data will remain an underutilised resource alongside
trials. Hospital data are relatively unified and offer
parameters useful for clinical and economic analysis.
Generally, hospital care constitutes a major driver
for patient care; therefore, the detailed electronic
data should be considered superior to self-reported
Table 2 Aspects to consider when choosing to obtain resource-use data using self-reported or electronic methods (Continued)
Aspects to
consider
Self-reported Electronic database
to use. HES outpatient diagnosis codes are poorly completed.
Baseline
measurements
Additional burden on patient and very rarely collected. Not an issue if the data are available for the baseline period
of interest.
Experience and
familiarity
Relatively easy for a researcher to get up to speed with. Design
for a clinical study may require knowledge of the clinical area to
accurately collect the resource-use cost drivers.
For large datasets, requires a data requisition form to be
completed which is not always easily understood. For
commissioning data, requires a contact with access to the
data and a data requisition form to be completed. For raw
data, requires knowledge of the service or to identify a person
who can extract the data (i.e. trained researcher of practice
nurse).
Information
Governance
Managed through standard ethics application methods. IG is a major concern when using electronic data. This
process can be navigated with expert guidance, although the
developing world of electronic data will always be a concern
for researchers.
Social care data Social care data could be self-reported and the exact type of so-
cial care data of interest could be specified within the
questionnaire.
Routinely collected social care data is not discussed in this
paper, but is an important aspect for future consideration.
Healthcare systems are more usable for obtaining data
relative to social care systems because of aspects such as the
inclusion of unique identifiers (NHS number of other pseudo
codes), relatively more standardised coded data, established
national data dictionaries, and national software and system
requirement.
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methods if hospital data are the main focus of the
analysis (with the caveat of requiring data sharing
agreements with third party providers and potentially
time-consuming extraction periods). However, for all
other resource-use, self-reported methods may be
the preferred option given the current complications
around electronic data.
Additional file
Additional file 1: Appendix S1. “Relevant websites for further
information”: this supplementary appendix includes websites (URLs) to
complement or supplement discussion points within the manuscript to
aid the reader learn more about the databases, software systems, and
national IT programmes. All websites were accessed as of 23rd August
2017. (DOCX 19 kb)
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